早晨
医学
傍晚
养生
痤疮
耐受性
异维甲酸
过氧化苯甲酰
痤疮治疗
维甲酸
不利影响
外科
内科学
皮肤病科
聚合物
化学
有机化学
物理
基因
生物化学
维甲酸
聚合
天文
作者
David Pariser,A Bucko,Richard G. Fried,Michael Jarratt,Steven Kempers,Leon Kircik,Anne W. Lucky,Elyse Rafal,Marta Rendon,Jonathan Weiss,David C. Wilson,Ana B. Rossi,Ratna Ramaswamy,Marge Nighland
出处
期刊:Journal of Drugs in Dermatology
[SanovaWorks]
日期:2010-07-01
卷期号:9 (7): 805-13
被引量:11
摘要
Topical tretinoin and benzoyl peroxide (BPO) are often prescribed in combination for the treatment of acne vulgaris; however, these products have not traditionally been administered simultaneously because of the potential for tretinoin degradation by BPO as well as the instability of tretinoin in daylight. The primary objective of this randomized, investigator-blinded, 12-week, phase 4 trial was to determine non-inferiority of a once-daily morning combination regimen of 5% BPO wash + tretinoin gel microsphere (TGM) 0.04% pump versus a sequential regimen (BPO in the morning/TGM in the evening) in patients > or = 12 years old with moderate facial acne vulgaris. The primary efficacy endpoint was the change from baseline in total acne lesions; the primary safety endpoint was the change in cutaneous irritation scores. The 247 participants (mean age: 18.5 years) were randomized to either the morning/morning regimen (n = 123) or the morning/evening regimen (n = 124). The morning/morning regimen was determined to be non-inferior to the morning/evening regimen in reduction of total acne lesions. The tolerability of both regimens was comparable. The morning/morning regimen is a safe and effective treatment option for patients with moderate acne vulgaris.
科研通智能强力驱动
Strongly Powered by AbleSci AI